| Protein | Alpha-2-antiplasmin |
| Gene | SERPINF2 |
| Status | Reviewed |
| Source | Bladder tumor; Breast tumor; Cerebrospinal fluid; HuH-7 cell line (Liver); Liver; Ovarian tumor; Plasma; Prostate; Prostate tumor; Serum; Serum (Colorectal cancer); Urine |
| Years | 2005-2015 |
| Site | Identified Peptides | Year(Publication ID) |
|---|---|---|
| 126 | AQnHTLQR | 2007(unpublished);2007(unpublished);2007(unpublished);2007(unpublished);2007(unpublished);2007 (Unpublished ); |
| 126 | GAQnHTLQ | 2014(33); |
| 126 | ALGAQnHTL | 2014(33); |
| 126 | GAQnHTLQR | 2014(14); |
| 126 | ALGAQnHTLQ | 2014(33); |
| 126 | LGAQnHTLQR | 2007(unpublished); |
| 126 | ALGAQnHTLQR | 2014(14); |
| 126 | ALGAQnHTLQRL | 2014(33); |
| 126 | LALGAQnHTLQR | 2015(unpublished); |
| 126 | ALSHLALGAQnHTL | 2014(33); |
| 126 | SHLALGAQnHTLQR | 2015(unpublished); |
| 126 | ALSHLALGAQnHTLQR | 2014(21); 2015(unpublished); |
| 126 | ALALSHLALGAQnHTLQR | 2015(unpublished); |
| 126 | SVALALSHLALGAQnHTLQR | 2005(81); 2015(unpublished); |
| 126 | LILSPLSVALALSHLALGAQnHTLQR | 2015(unpublished); |
| 126 | AMMAFTADLFSLVAQTSTCPNLILSPLSVALALSHLALGAQnHTLQR | 2014(35); |
| 295 | KNnMSFVVLVPTHF | 2014(33); |
| 295 | NnMSFVVLVPTHFE | 2014(33); |
| 295 | NnMSFVVLVPTHFEWNVSQVLANLSWDTLHPPLVWERPTK | 2005(81); 2013(38); 2014(35); 2015(unpublished); |
| 309 | NNMSFVVLVPTHFEWnVSQVLANLSWDTLHPPLVWERPTK | 2005(81); 2013(38); 2014(35); 2015(unpublished); |
| 316 | AnLSWDTLHPPLVWERPTK | 2007(unpublished);2007(unpublished);2007; |
| 316 | NNMSFVVLVPTHFEWNVSQVLAnLSWDTLHPPLVWERPTK | 2005(81); 2013(38); 2014(35); 2015(unpublished); |
| 1 | 11 | 21 | 31 | 41 | 51 | 61 | 71 | 81 | 91 |
| MALLWGLLVL | SWSCLQGPCS | VFSPVSAMEP | LGRQLTSGPN | QEQVSPLTLL | KLGNQEPGGQ | TALKSPPGVC | SRDPTPEQTH | RLARAMMAFT | ADLFSLVAQT |
| 101 | 111 | 121 | 131 | 141 | 151 | 161 | 171 | 181 | 191 |
| STCPNLILSP | LSVALALSHL | ALGAQNHTLQ | RLQQVLHAGS | GPCLPHLLSR | LCQDLGPGAF | RLAARMYLQK | GFPIKEDFLE | QSEQLFGAKP | VSLTGKQEDD |
| 201 | 211 | 221 | 231 | 241 | 251 | 261 | 271 | 281 | 291 |
| LANINQWVKE | ATEGKIQEFL | SGLPEDTVLL | LLNAIHFQGF | WRNKFDPSLT | QRDSFHLDEQ | FTVPVEMMQA | RTYPLRWFLL | EQPEIQVAHF | PFKNNMSFVV |
| 301 | 311 | 321 | 331 | 341 | 351 | 361 | 371 | 381 | 391 |
| LVPTHFEWNV | SQVLANLSWD | TLHPPLVWER | PTKVRLPKLY | LKHQMDLVAT | LSQLGLQELF | QAPDLRGISE | QSLVVSGVQH | QSTLELSEVG | VEAAAATSIA |
| 401 | 411 | 421 | 431 | 441 | 451 | 461 | 471 | 481 | 491 |
| MSRMSLSSFS | VNRPFLFFIF | EDTTGLPLFV | GSVRNPNPSA | PRELKEQQDS | PGNKDFLQSL | KGFPRGDKLF | GPDLKLVPPM | EEDYPQFGSP | K |
| ID | Publication |
|---|---|
| 14 | Liu Y, Chen J, Sethi A, Li QK, Chen L, Collins B, Gillet LC, Wollscheid B, Zhang H, Aebersold R: Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Molecular & Cellular Proteomics 2014, 13:1753-1768. |
| 21 | Liu L, Yu M, Zhang Y, Wang C, Lu H: Hydrazide Functionalized Core-Shell Magnetic Nanocomposites for Highly Specific Enrichment of N-Glycopeptides. Acs Applied Materials & Interfaces 2014, 6:7823-7832. |
| 33 | Zhu J, Sun Z, Cheng K, Chen R, Ye M, Xu B, Sun D, Wang L, Liu J, Wang F, Zou H: Comprehensive Mapping of Protein N-Glycosylation in Human Liver by Combining Hydrophilic Interaction Chromatography and Hydrazide Chemistry. Journal of Proteome Research 2014, 13:1713-1721. |
| 35 | Chen J, Shah P, Zhang H: Solid phase extraction of N-linked glycopeptides using hydrazide tip. Analytical chemistry 2013, 85:10670-10674. |
| 38 | Kaji H, Ocho M, Togayachi A, Kuno A, Sogabe M, Ohkura T, Nozaki H, Angata T, Chiba Y, Ozaki H, et al: Glycoproteomic Discovery of Serological Biomarker Candidates for HCV/HBV Infection-Associated Liver Fibrosis and Hepatocellular Carcinoma. Journal of Proteome Research 2013, 12:2630-2640. |
| 81 | Liu T, Qian WJ, Gritsenko MA, Camp DG, Monroe ME, Moore RJ, Smith RD: Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. Journal of Proteome Research 2005, 4:2070-2080. |